Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT800 prophylaxis in previously treated severe hemophilia A (Phase III, China)
CTR20181922Phase 3Completed
- Sponsor
- Shenzhou Cell Engineering Co., Ltd.
- Start
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Shenzhou Cell Engineering Co., Ltd.. Started Oct 2018; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20181922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181922.